Alireza Nami is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 1,073 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JanssenProgram year202515 paymentsResearch$156,697
- AbbVieProgram year202524 paymentsResearch$119,104
- AstraZenecaProgram year20251 paymentResearch$100,711
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
49.3%RANK Ligand Inhibitor36.2%Denosumab99%Prolia1%Part D + Part B≥32 patientsCentral alpha-2 Adrenergic Agonist5%Tizanidine Hcl100%Part D≥106 patients+ 7 more classes in this area
Nervous system
19.6%Gabapentinoids7.4%Gabapentin70%Pregabalin30%Part D≥113 patientsSNRI6.3%Duloxetine Hcl100%Part D≥146 patients+ 10 more classes in this area
Cancer & immunology
13.5%Folate Analog Metabolic Inhibitor8.4%Methotrexate sodium47%Methotrexate45%Rasuvo3%Otrexup3%Methotrexate Sodium2%Part D + Part B<11 patientsAntirheumatic Agent1.3%Leflunomide100%Part D≥30 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”